These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 32724855)
21. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer. Binnemars-Postma K; Bansal R; Storm G; Prakash J FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614 [TBL] [Abstract][Full Text] [Related]
22. Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A/STAT6 Pathway. Jiang M; Qi Y; Huang W; Lin Y; Li B Cells; 2022 Nov; 11(21):. PubMed ID: 36359867 [TBL] [Abstract][Full Text] [Related]
23. A novel targeted iron oxide nanocarrier for inhibiting M2-type macrophages in the tumor microenvironment. Tian K; Feng R; Wang X; Wu X; Li L; Liu W; Wu R J Cancer Res Ther; 2022 Sep; 18(5):1409-1416. PubMed ID: 36204890 [TBL] [Abstract][Full Text] [Related]
24. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages. Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411 [TBL] [Abstract][Full Text] [Related]
25. Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide. Lee C; Jeong H; Bae Y; Shin K; Kang S; Kim H; Oh J; Bae H J Immunother Cancer; 2019 Jun; 7(1):147. PubMed ID: 31174610 [TBL] [Abstract][Full Text] [Related]
26. Adoptive transfer of Fe Zhang Y; Liu S; Li D; He C; Wang D; Wei M; Zheng S; Li J Colloids Surf B Biointerfaces; 2023 Sep; 229():113452. PubMed ID: 37474429 [TBL] [Abstract][Full Text] [Related]
27. M2-type macrophage-targeted delivery of IKKβ siRNA induces M2-to-M1 repolarization for CNV gene therapy. Zhang Y; Chu B; Fan Q; Song X; Xu Q; Qu Y Nanomedicine; 2024 Apr; 57():102740. PubMed ID: 38458368 [TBL] [Abstract][Full Text] [Related]
28. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction. Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192 [TBL] [Abstract][Full Text] [Related]
29. Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy. Liu L; Yi H; He H; Pan H; Cai L; Ma Y Biomaterials; 2017 Jul; 134():166-179. PubMed ID: 28463694 [TBL] [Abstract][Full Text] [Related]
30. Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy Zhang S; Xie F; Li K; Zhang H; Yin Y; Yu Y; Lu G; Zhang S; Wei Y; Xu K; Wu Y; Jin H; Xiao L; Bao L; Xu C; Li Y; Lu Y; Gao J Acta Pharm Sin B; 2022 Jul; 12(7):3124-3138. PubMed ID: 35865102 [TBL] [Abstract][Full Text] [Related]
32. Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity. Qian H; Zhou T; Fu Y; Guo M; Yang W; Zhang D; Fang W; Yao M; Shi H; Chai C; Cheng W; Ding S; Chen T Mol Ther Nucleic Acids; 2022 Mar; 27():763-773. PubMed ID: 35116188 [TBL] [Abstract][Full Text] [Related]
33. NIR-Actuated Targeted Janus Nanomotors Remodel Immunosuppressive Tumor Microenvironment for Augmented Cancer Immunotherapy. Zhou X; Ma E; Zhang Y; Xing Y; Xu W; Chen L; Zhou H; Zhang X; Jiang C; Xu K; Wang H; Zheng S Adv Healthc Mater; 2024 Jan; 13(2):e2302272. PubMed ID: 37824087 [TBL] [Abstract][Full Text] [Related]
34. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors. Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313 [TBL] [Abstract][Full Text] [Related]
35. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization. Shi L; Gu H Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555 [TBL] [Abstract][Full Text] [Related]
36. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Song Y; Tang C; Yin C Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030 [TBL] [Abstract][Full Text] [Related]
37. Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy. Zheng X; Liu Y; Liu Y; Zang J; Wang K; Yang Z; Chen N; Sun J; Huang L; Li Y; Xue L; Zhi H; Zhang X; Yu M; Chen S; Dong H; Li Y Biomaterials; 2024 Apr; 306():122474. PubMed ID: 38271788 [TBL] [Abstract][Full Text] [Related]
38. Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression. Kuznetsova AB; Kolesova EP; Parodi A; Zamyatnin AA; Egorova VS Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794298 [TBL] [Abstract][Full Text] [Related]
40. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages. Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]